Yan Song

Managing Principal
Yan Song
Boston

Education

Ph.D., epidemiology, University of California, Los Angeles; M.S., epidemiology and biostatistics, and M.B.B.S., medicine, Peking University

Summary of Experience

Dr. Song is an epidemiologist with training in medicine and biostatistics and extensive experience applying health economics and outcomes research (HEOR) to complex health care decisions. He advises pharmaceutical and biotech clients, as well as health technology organizations, on evidence generation strategies and leads the design and implementation of advanced RWE studies and pharmacoeconomic modeling solutions. He works with clinical, medical, market access, and strategy teams, drawing on clinical trial data, RWE, and economic analyses to inform product and portfolio decisions. Dr. Song has provided cross-indication consulting on multiple high-revenue pharmaceutical products as well as novel pipeline therapies. Beyond generating evidence, he helps clients critically interpret research findings, assess the strengths and limitations of available evidence, and translate results into actionable insights to support clinical, regulatory, payer, and strategic decision making.

His research evaluates and compares the clinical, economic, and humanistic impacts of diseases and treatments across a broad range of therapeutic areas, including oncology, hematology, cardiology, infectious diseases and vaccines, dermatology, rheumatology, and endocrinology. He draws on diverse data sources, including clinical trials, administrative claims, electronic health records, medical chart reviews, surveys, qualitative interviews, and medical literature. His work spans disease epidemiology and causal inference, burden of illness, treatment and management patterns, comparative effectiveness, and individualized medicine. Dr. Song has published more than 100 peer-reviewed journal articles and given more than 140 presentations at international conferences on medical and health care research.

Yan Song
Practices